173 related articles for article (PubMed ID: 25493603)
1. Preconception antiretroviral therapy and birth defects: what is needed?
Bulterys M; Berry RJ; Watts DH
AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
[No Abstract] [Full Text] [Related]
2. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia.
Liu KC; Farahani M; Mashamba T; Mawela M; Joseph J; Van Schaik N; Honey E; Gill M; Jassat W; Stringer EM; Chintu N; Marlink RG
AIDS; 2014 Sep; 28(15):2259-68. PubMed ID: 25115319
[TBL] [Abstract][Full Text] [Related]
3. HIV transmission from mother to child--HAART compared with dual therapy.
Theron G; Nellensteijn M; Theron A; Louw J
S Afr Med J; 2009 Oct; 99(10):717, 720. PubMed ID: 20128268
[No Abstract] [Full Text] [Related]
4. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy and congenital abnormalities in infants born to HIV-1-infected women in the United Kingdom and Ireland, 1990 to 2003.
Townsend CL; Tookey PA; Cortina-Borja M; Peckham CS
J Acquir Immune Defic Syndr; 2006 May; 42(1):91-4. PubMed ID: 16763496
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
Kourtis AP
J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
[No Abstract] [Full Text] [Related]
7. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
8. Beginning antiretroviral therapy for patients with HIV.
Johnson JA; Sax PE
Infect Dis Clin North Am; 2014 Sep; 28(3):421-38. PubMed ID: 25151564
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
Coovadia H
N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
[No Abstract] [Full Text] [Related]
10. [HIV-infection].
Wasmuth JC; Rockstroh JK
Dtsch Med Wochenschr; 2007 Mar; 132(13):673-83; quiz 685-6. PubMed ID: 17377882
[No Abstract] [Full Text] [Related]
11. Protecting the next generation--eliminating perinatal HIV-1 infection.
Mofenson LM
N Engl J Med; 2010 Jun; 362(24):2316-8. PubMed ID: 20554987
[No Abstract] [Full Text] [Related]
12. Antiretroviral therapy during pregnancy and premature birth: analysis of Swiss data.
Rudin C; Spaenhauer A; Keiser O; Rickenbach M; Kind C; Aebi-Popp K; Brinkhof MW; ;
HIV Med; 2011 Apr; 12(4):228-35. PubMed ID: 20726902
[TBL] [Abstract][Full Text] [Related]
13. What is the risk of major congenital abnormalities among women on antiretroviral therapy?
Zash RM; Williams P; Holmes LB
AIDS; 2018 Jan; 32(3):403-404. PubMed ID: 29309347
[No Abstract] [Full Text] [Related]
14. Association between atazanavir plasma levels and renal function in HIV-positive individuals on antiretroviral therapy with undetectable viral load.
Luz AJ; Poeta J; Linden R; Antunes MV; Caminha LI; Callegari-Jacques SM; Sprinz E
Int J Antimicrob Agents; 2013 May; 41(5):497-8. PubMed ID: 23453620
[No Abstract] [Full Text] [Related]
15. HIV trial attacked.
Check Hayden E
Nature; 2014 Jun; 510(7505):324. PubMed ID: 24943939
[No Abstract] [Full Text] [Related]
16. Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.
Prieto LM; González-Tomé MI; Muñoz E; Fernández-Ibieta M; Soto B; Álvarez A; Navarro ML; Roa MÁ; Beceiro J; de José MI; Olabarrieta I; Lora D; Ramos JT;
BMC Infect Dis; 2014 Dec; 14():700. PubMed ID: 25808698
[TBL] [Abstract][Full Text] [Related]
17. Considerations on the potential teratogenic effects of antiretroviral therapy.
Meli M; Vicidomini S; Bartoloni A
Intern Emerg Med; 2006; 1(3):249-50. PubMed ID: 17120478
[No Abstract] [Full Text] [Related]
18. Is Option B+ the best choice?
Coutsoudis A; Goga A; Desmond C; Barron P; Black V; Coovadia H
Lancet; 2013 Jan; 381(9863):269-71. PubMed ID: 23351797
[No Abstract] [Full Text] [Related]
19. Safety and efficacy of fosamprenavir in human immunodeficiency virus-infected pregnant women.
Martorell C; Theroux E; Bermudez A; Garb J; Kronschnabel D; Oie K
Pediatr Infect Dis J; 2010 Oct; 29(10):985. PubMed ID: 20859183
[No Abstract] [Full Text] [Related]
20. Antiretroviral therapy and preterm birth in HIV-infected women.
Short CE; Taylor GP
Expert Rev Anti Infect Ther; 2014 Mar; 12(3):293-306. PubMed ID: 24502750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
